Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma
Article in Journal of Hepatocellular Carcinoma (March 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Journal of Hepatocellular Carcinoma (March 2024)
Article in Journal of Molecular Liquids (March 2024)
Article in World Journal of Hepatology (February 2024)